What is the appropriate workup for a patient presenting with polyuria?

Workup of Polyuria

Begin the workup by measuring serum sodium, serum osmolality, and urine osmolality simultaneously as your initial biochemical assessment 1.

Initial Clinical Assessment

When evaluating polyuria, first confirm true polyuria (>3 L/24h urine output) and determine the clinical context 2, 3:

• In children: Suspect diabetes insipidus if presenting with polyuria, polydipsia, failure to thrive, and hypernatremic dehydration with inappropriately low urine osmolality (mostly <200 mOsm/kg H₂O) 1
• In adults: Suspect diabetes insipidus with unexplained polydipsia and polyuria 1

Algorithmic Approach Based on Urine Osmolality

Step 1: Classify by Urine Osmolality

• Urine osmolality >300 mOsm/L: Solute-induced polyuria (osmotic diuresis) 2

  • Check blood glucose to rule out poorly controlled diabetes mellitus (which presents with high urine osmolality, hyperglycemia, and glucosuria) 1
  • Calculate 24-hour urinary osmole excretion to identify excessive solute load 3

• Urine osmolality <150 mOsm/L: Water diuresis (hypotonic polyuria) - proceed to Step 2 2

• Urine osmolality 150-300 mOsm/L: Mixed picture requiring further evaluation 2

Step 2: For Hypotonic Polyuria - Measure Copeptin

Baseline copeptin measurement is the modern diagnostic approach 4, 5, 6:

• Copeptin >21.4 pmol/L: Diagnostic for nephrogenic diabetes insipidus in adults 1
• Copeptin <21.4 pmol/L: Requires stimulated testing to differentiate central diabetes insipidus from primary polydipsia 1, 5

Step 3: Hypertonic Saline Stimulation Test (if baseline copeptin <21.4 pmol/L)

This test has superior diagnostic accuracy compared to the traditional water deprivation test 5:

• Stimulated copeptin ≥4.9 pmol/L: Rules out central diabetes insipidus 5
• Stimulated copeptin <4.9 pmol/L: Confirms central diabetes insipidus (AVP deficiency) 5
• Critical caveat: Close sodium monitoring during the test is mandatory to prevent dangerous hypernatremia 5

Genetic Testing

Perform early genetic testing in patients with clinical symptoms of suspected nephrogenic diabetes insipidus 1:

• Use a massively parallel sequencing-based multigene panel including at minimum AVPR2, AQP2, and AVP genes 1
• Test AVPR2 and AQP2 in all symptomatic females 1
• Genetic testing should be performed in laboratories accredited for diagnostic genetic testing 1

Common Pitfalls to Avoid

• Do not rely solely on water deprivation testing: This traditional test has limitations and unsatisfying diagnostic accuracy, particularly in differentiating primary polydipsia from mild forms of diabetes insipidus 5, 6
• Do not overlook secondary causes: Consider Bartter syndrome (with polyhydramnios, prematurity, hypercalciuria, nephrocalcinosis), distal renal tubular acidosis (with acidosis and hypercalciuria), nephronophthisis/ciliopathies (with CKD and associated anomalies), and lithium-induced nephrogenic diabetes insipidus in adults 1
• Do not forget to check medication history: Lithium is a common cause of acquired nephrogenic diabetes insipidus 1